SNY Latest Headlines

Sanofi Updates Long-Term Frexalimab Study as Investors Watch Multiple Sclerosis Pipeline

at www.tipranks.com (Thu, 12-Nov 11:33 AM)

Sanofi (SNY) Teams With ScionxBio to Pursue Long-Acting mRNA Candidates Using the TERA Platform

Market Chameleon (Tue, 20-Oct 9:29 AM)

Sanofi’s $1 Billion Upfront Bet on Regeneron Antibodies Highlights Where AI-Driven Biologics Must Prove Themselves

Market Chameleon (Thu, 15-Oct 7:10 AM)